Como parte de las conclusiones del informe, se menciona que la baja persistencia reportada genera interrogantes sobre la viabilidad de invertir en terapias GLP-1 para la obesidad, dado que muchos pacientes no sostienen los beneficios clnicos con el paso del tiempo
In August 2025, a review found that flavonoids, which contribute to bitter flavors in, say, citrus or hops, can stimulate GLP-1 release, too
With respect to VPA, this agent depletes carnitine stores, especially during long-term or high-dose therapy, through various synergistic mechanisms [22, 3841]
Before, I'd skip meals because I wasn't hungry and then wonder why I felt terrible
Off-label use has created shortages for people with diabetes who need them most
doi: 10.1371/journal.pone.0025471 52 YeeCLYangRBttgerBFingerTEKinnamonJC